BioSpace News Archive

Sanofi and Inhibrx, Inc., a publicly traded clinical-stage biopharmaceutical company focused on developing a broad pipeline of novel biologic therapeutic candidates, have entered into a definitive agreement under which Sanofi has agreed to acquire Inhibrx following the spin-off of non-INBRX-101 assets into New Inhibrx.

HEPHAISTOS-Pharma, a biotechnology company developing next generation immunotherapies against cancer, announced that it has raised a €2 million seed round to finance GMP transfer and advance its lead candidate towards the clinic.

Amadix, a Spanish biotech company, announced that PreveCol®, its colorectal cancer screening blood test, has received Breakthrough Device Designation from the U.S. Food and Drug Administration.

AngioDynamics Announces FDA 510(k) Clearance of Auryon XL Radial Access Catheter to Treat Peripheral Arterial Disease.

Scholar Rock Announces FDA Clearance of IND Application to Initiate Phase 2 Proof-of-Concept Trial with Apitegromab to Treat Obesity.

Harbour BioMed announced that the Company has been granted the clearance of Investigational New Drug from the Food and Drug Administration of the United States to initiate the first-in-human clinical trial in the U.S. for bispecific antibody HBM9027.